Frontlight ResearchEarly access
Trial site
Hematology Hospital of Chinese Academy of Medical Sciences
- 3running trials
- 4closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers1 trial
- Chronic lymphocytic leukaemia1 trial
- Haemophilia1 trial
- Immune thrombocytopenia (ITP)1 trial
- Myelodysplastic syndromes1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 34 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Active, not recruiting2 trials
- Completed2 trials
- Terminated2 trials
- Recruiting1 trial
- Lead sponsor
- Chengdu Suncadia Medicine Co., Ltd.1 trial
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1 trial
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1 trial
- Chongqing Peg-Bio Biopharm Co., Ltd.1 trial
- Institute of Hematology & Blood Diseases Hospital, China1 trial
- and 2 more
Running trials
Recruiting
CD5 CART for the Treatment of Relapsed and Refractory CD5 Hematological Tumors
Active, not recruiting
P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
Closed trials
Completed
Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)
Completed
Terminated
Terminated
Site data: ClinicalTrials.govUpdated 13 Nov 2026